Cibus (CBUS) Long-Term Deferred Tax (2020)

Cibus (CBUS) posted Long-Term Deferred Tax of $44.5 million for Q4 2020.

Cibus (CBUS) Long-Term Deferred Tax (2020) Analysis & Trends

Cibus has reported Long-Term Deferred Tax for 1 years, with the latest figure at $44.5 million in Q4 2020.

Quarterly Long-Term Deferred Tax changed N/A year-over-year to $44.5 million in Q4 2020, while the trailing twelve-month figure through Dec 2020 was $44.5 million (changed N/A YoY) and the FY2020 annual result came in at $44.5 million, changed N/A from the prior year.
Long-Term Deferred Tax held at $44.5 million in Q4 2020 per CBUS's latest filing.
Over five years, Long-Term Deferred Tax peaked at $44.5 million in Q4 2020 and troughed at $44.5 million in Q4 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	137.11 Bn	129.26 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	84.98 Bn	76.99 Bn	3.93 Bn
3	Argenx Se	64.52 Bn	59.33 Bn	1.37 Bn
4	Moderna	53.23 Bn	48.09 Bn	52.00 Mn
5	BeOne Medicines	41.23 Bn	36.14 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	30.65 Bn	27.34 Bn	992.69 Mn
7	Insmed	27.15 Bn	25.99 Bn	358.27 Mn
8	Royalty Pharma	26.98 Bn	26.14 Bn	-
9	BioNTech SE	26.78 Bn	8.39 Bn	668.28 Mn
10	Cibus	131.25 Mn	110.82 Mn	-

Download Data

Date	Value
Dec 31, 2020	44.51 Mn